Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

60.69

+0.02 (0.03%)

as of Jul 23, 2026, 8:00:00 pm Market Open.

1632 watching

Investor Insights

Jul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed perspectives from various analysts, reflecting both its potential and current market position. While many experts acknowledge MFC's solid dividend yield and growth prospects, particularly in Asia, concerns about valuation and market conditions persist. The stock appears to be trading around 2x book value and has shown slow but steady growth, attracting attention from those looking for income rather than explosive growth. The consensus among experts is to proceed with caution and consider market pullbacks for optimal entry points, though some view the stock as a good long-term hold due to its stable dividend and cash flow. Overall, while there are positive signs, such as asset management improvements and capital growth, analysts advise careful monitoring given the mixed signals surrounding the broader financial sector's performance.

Consensus

Cautious

Valuation

Fair Value

Similar

SLF

DON'T BUY

(Market Call Minute) Not too keen on them. How well can they invest the premiums while they are holding onto them.

Wealthica Track your Stocks in your Watch List

BUY

It will be higher in a couple of years. He believes in the management. Great diversity. Great levered play on the Canadian market and economy. Good story with lots of life left in it.

BUY

Likes a number of things about it. Trades at book value. Likes life insurance business in Asia. Question mark lies in its exposure to the markets. He thinks that is discounted in stock price and continues to buy it.

HOLD

Same predicament as the rest of us as investors. It has to invest premiums in the market, which is difficult. Has new boss who take action like trimming the dividend. He is not sure what the future is. He doesn’t think it will go anywhere. Has halved his position.

COMMENT

Their variable annuity business got them into trouble.

BUY

Took a half position (2%). Have great exposure in China and will be in India. Good entry point for a 3-year view.

BUY

Recently re-invested in. In 2009 they shocked the street with their second equity issue. They are a global leader that disappointed the market with the raising of equity. He accumulated a half position when it went under $19. The time to buy these types of companies is when no one likes them. They have a capital base that should withstand pressures.

BUY

Trading at 10X earnings. Have bolstered the balance sheet and it is very sound financially. Almost 3% yield.

BUY

(Market Call Minute) Going in the right direction.

BUY

Dividend being cut in half took him by surprise, but once it happened he decided to stick with the stock. Dividend will increase over time. Very well positioned in the life business, particularly with its growing business in Asia. Expects more upside in 2010 than what the banks will have.

HOLD

It is unfortunate about the dividend cut and the equity raise of $2.5 million but all the bad news is in the price. Dividend will be back where it was 5 years ago.

BUY

This is one of the better plays in the financial sector. Capital position is much better shape than it was. Have international growth. Valuation is attractive. Would take this over the bank stocks currently. 2.6% yield.

TOP PICK

Premier insurance company in the country but has gone through some hard times because of exposure to the equity markets. Cut their dividends and raised a lot of equity so a lot of shareholders threw in the towel but the name of the game for financial companies is going to be capital.

SELL

This would be his 3rd choice in Canadian lifecos. It ended up being a leveraged play on the US stock market. Still has 75% of their equity exposure unhedged. Has not been shareholder friendly. Have raised massive amounts of money twice to build up their balance sheet as well as cutting the dividend in half.

DON'T BUY

Very large, high-quality Canadian life insurance company. Ran into problems last year with their balance sheet and was forced to get significant financing. In the life insurance companies it has the most exposure to the overall equity market.

Showing 1,516 to 1,530 of 2,283 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

John Stephenson

Stephenson & Company Capital Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)